For the 12th consecutive year, OMRF hosted a Halloween event for more than 70 trick-or-treaters from Positive Tomorrows.
Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.
So, what exactly happens inside your body when things go bump in the night?
The project will focus on comparing certain immune cells in patients with Sjögren’s to those of healthy controls.
Seventh annual concert and golf tournament benefit research
Two grants will enable OMRF scientists to examine genes thought to play a role in lupus.